Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | navb-ex231_9.htm |
| EX-32.2 - EX-32.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | navb-ex322_14.htm |
| EX-32.1 - EX-32.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | navb-ex321_13.htm |
| EX-31.1 - EX-31.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | navb-ex311_15.htm |
| EX-31.2 - EX-31.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | navb-ex312_16.htm |
| 10-K - 10-K - NAVIDEA BIOPHARMACEUTICALS, INC. | navb-10k_20151231.htm |
| EX-24.1 - EX-24.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | navb-ex241_10.htm |
Exhibit 21.1
Subsidiaries of Navidea Biopharmaceuticals, Inc.
|
|
|||
|
|
|
|
|
|
Subsidiaries |
Jurisdiction of Incorporation |
Percentage Owned by Registrant |
|
|
Cardiosonix Ltd. |
Israel |
100% |
|
|
Navidea Biopharmaceuticals Limited |
United Kingdom |
100% |
|
|
Macrophage Therapeutics, Inc. |
Delaware, United States |
99.9% |
|